Prevalence of Metabolic Syndrome in Psoriatic Arthritis and Rheumatoid Arthritis

1. .Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol. 2008;7:373-377.Search in Google Scholar

2. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31:1000-1006.10.1093/eurheartj/ehp567289473620037179Search in Google Scholar

3. Jamnitski A, Symmons D, Peters MJ, et al. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72:211-216.10.1136/annrheumdis-2011-20119422532629Search in Google Scholar

4. Ramonda R, Lo Nigro A, Modesti V, et al. Atherosclerosis in psoriatic arthritis. Autoimmun Rev. 2011;10:773-778.10.1016/j.autrev.2011.05.02221684355Search in Google Scholar

5. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007;36:203-209.10.1016/j.semarthrit.2006.09.00117067658Search in Google Scholar

6. Vitale C, Marazzi G, Volterrani M, et al. Metabolic syndrome. Minerva Med. 2006;97:219-229.Search in Google Scholar

7. Raychaudhuri SK, Chatterjee S, Nguyen C, et al. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metabolic Syndrome and Related Disorders. 2010;8:331-334.10.1089/met.2009.0124312970120367239Search in Google Scholar

8. Toms TE, Panoulas VF, John H, Douglas KM, Kitas GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther. 2009;11:R110.10.1186/ar2765274579219607680Search in Google Scholar

9. Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H. The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls. Int J Rheum Dis. 2011;14:248-254.10.1111/j.1756-185X.2011.01595.x21816020Search in Google Scholar

10. Karakoca M, Batmaza I, Sariyildiza MA, et al. The Relationship of Metabolic Syndrome With Disease Activity and the Functional Status in Patients With Rheumatoid Arthritis. J Clin Med Res. 2012;4:279-285.10.4021/jocmr1001w340962422870176Search in Google Scholar

11. Mok CC, Ko GTC, Ho LY, Yu KL, Chan PT. Prevalence of Atherosclerotic Risk Factors and the Metabolic Syndrome in Patients With Chronic Inflammatory Arthritis. Arthritis Care & Research. 2011,63:195-202.10.1002/acr.2036320890981Search in Google Scholar

12. Matei C., Pop I., Jurcuț R, et al. Romanian Multicentric Study of the Prevalence of Metabolic Syndrome - ROMES, Hellenic Journal of Cardiology, 2008: 49: 303-309.Search in Google Scholar

13. Tracy Y. Zhu, Edmund K. Li, Lai-Shan Tam. Cardiovascular Risk in Patients with Psoriatic Arthritis. Int J Rheumatol. 2012; 2012:714321.Search in Google Scholar

14. Madanagobalane S , Anandan S . Prevalence of metabolic syndrome in south Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study. Indian Journal of Dermatology. 2012;27:353-357.Search in Google Scholar

15. Sahebari M, Goshayeshi L, Mirfeizi Z, et al. Investigation of the Association between Metabolic Syndrome and Disease Activity in Rheumatoid Arthritis. The Scientific World Journal, 2011;11:1195-1205.10.1100/tsw.2011.111572008421666989Search in Google Scholar

16. Sattar N, McCarey D, Capell H, McInnes I. Explaining how ‘highgrade’ systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-2963.10.1161/01.CIR.0000099844.31524.0514676136Search in Google Scholar

17. Chung CP, Oeser A, Solus JF, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196:756-763.10.1016/j.atherosclerosis.2007.01.00417266963Search in Google Scholar

18. Karvounaris SA, Sidiropoulos PI, Papadakis JA, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007;66:28-33.10.1136/ard.2006.053488179840616793841Search in Google Scholar

19. Escalante A, Haas R, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165:1624-1629.10.1001/archinte.165.14.162416043681Search in Google Scholar